Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06708429
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:02.929881+00:00
Published At
2026-04-24T00:00:00+00:00
Record Updated At
2026-04-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lynch Syndrome", "Lynch Syndrome I", "Lynch Syndrome II", "Lynch Syndrome I (Site-specific Colonic Cancer)", "HNPCC", "HNPCC Gene Mutation", "Hereditary Cancer Syndrome", "Hereditary Cancer", "MLH1 Gene Mutation", "MLH1 Gene Deletion+Duplication", "MLH1 Loss of Expression", "MLH1 Gene Inactivation", "MSH2 Gene Mutation", "MSH2 Gene Deletion+Duplication", "MSH2 Loss of Expression", "MSH2 Gene Inactivation", "MSH6 Gene Mutation", "MSH6 Loss of Expression", "MSH6 Gene Inactivation", "PMS2 Gene Mutation", "PMS2 Gene Inactivation", "PMS2 Loss of Expression"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-24"
protocolSection.identificationModule.nctId
"NCT06708429"
protocolSection.identificationModule.officialTitle
"Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lynch Syndrome (protocolSection.conditionsModule.conditions)
  • Lynch Syndrome I (protocolSection.conditionsModule.conditions)
  • Lynch Syndrome II (protocolSection.conditionsModule.conditions)
  • Lynch Syndrome I (Site-specific Colonic Cancer) (protocolSection.conditionsModule.conditions)
  • HNPCC (protocolSection.conditionsModule.conditions)
  • HNPCC Gene Mutation (protocolSection.conditionsModule.conditions)
  • Hereditary Cancer Syndrome (protocolSection.conditionsModule.conditions)
  • Hereditary Cancer (protocolSection.conditionsModule.conditions)
  • MLH1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MLH1 Gene Deletion+Duplication (protocolSection.conditionsModule.conditions)
  • MLH1 Loss of Expression (protocolSection.conditionsModule.conditions)
  • MLH1 Gene Inactivation (protocolSection.conditionsModule.conditions)
  • MSH2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MSH2 Gene Deletion+Duplication (protocolSection.conditionsModule.conditions)
  • MSH2 Loss of Expression (protocolSection.conditionsModule.conditions)
  • MSH2 Gene Inactivation (protocolSection.conditionsModule.conditions)
  • MSH6 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MSH6 Loss of Expression (protocolSection.conditionsModule.conditions)
  • MSH6 Gene Inactivation (protocolSection.conditionsModule.conditions)
  • PMS2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • PMS2 Gene Inactivation (protocolSection.conditionsModule.conditions)
  • PMS2 Loss of Expression (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.